Patents by Inventor Kevin Edward Burdon Parkes

Kevin Edward Burdon Parkes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of HPV E1 helicase enzyme
    Patent number: 6703387
    Abstract: The invention is concerned with novel benzodiazepine derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are inhibitors of the human papillomavirus E1 helicase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HPV mediated diseases.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: March 9, 2004
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David N. Hurst, Philip Stephen Jones, Kevin Edward Burdon Parkes, Martin John Parratt, Francis Xavier Wilson
  • Anti-HIV pyrazole derivatives
    Patent number: 6538015
    Abstract: The invention is concerned with novel pyrazole derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HIV mediated process.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: March 25, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Brian William Dymock, Adrian Liam Gill, Philip Stephen Jones, Kevin Edward Burdon Parkes, Martin John Parratt
  • Anti-HIV imidazolone derivatives
    Patent number: 6518293
    Abstract: The invention is concerned with novel imidazolone derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents against HIV infection.
    Type: Grant
    Filed: November 6, 2001
    Date of Patent: February 11, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Brian William Dymock, Philip Stephen Jones, John Herbert Merrett, Kevin Edward Burdon Parkes, Martin John Parratt, Daryl Simon Walter
  • Inhibitors of HPV E1 helicase enzyme
    Publication number: 20020128262
    Abstract: The invention is concerned with novel benzodiazepine derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are inhibitors of the human papillomavirus E1 helicase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HPV mediateddiseases.
    Type: Application
    Filed: June 26, 2001
    Publication date: September 12, 2002
    Inventors: David N. Hurst, Philip Stephen Jones, Kevin Edward Burdon Parkes, Martin John Parratt, Francis Xavier Wilson